How The Insight Molecular Diagnostics (IMDX) Story Is Shifting With New Funding And FDA Catalyst [Yahoo! Finance]
Insight Molecular Diagnostics Inc. (IMDX)
Company Research
Source: Yahoo! Finance
The raised price target from $8 to $12 puts Insight Molecular Diagnostics more firmly on the radar for investors tracking valuation shifts. Analysts are linking this higher price target to the recent $26,000,000 capital raise and the upcoming FDA submission for GraftAssureDx, which they identify as key factors behind the updated outlook. The following sections explain how this evolving analyst narrative could influence how you follow the story from here. Stay updated as the Fair Value for Insight Molecular Diagnostics shifts by adding it to your watchlist or portfolio . Alternatively, explore our Community to discover new perspectives on Insight Molecular Diagnostics. What Wall Street Has Been Saying ?? Bullish Takeaways Lake Street lifted its price target on Insight Molecular Diagnostics to $12 from $8, indicating higher conviction around the company's valuation based on current information. The recent $26,000,000 capital raise is viewed by Lake Street as giving Insight ca
Show less
Read more
Impact Snapshot
Event Time:
IMDX
Last Price
Price Change
Price Change%
Volume Shares
Max Up
Max Down
%
Volume Ratio
Performance Comparison
Updated
|
Event Day
Stock performance from the time of news release until the following 4pm ET market close
|
Last price at news event
|
Since Event
Multi-day stock performance from the time of the news release
|
|---|---|---|
|
EVENT DAY
Stock performance from the time of news release until the following 4pm ET market close
|
LAST
PRICE AT NEWS EVENT |
SINCE EVENT
Multi-day stock performance from the time of the news release
|
| Last Price | ||
| VWAP | ||
|
High:
|
Max Up |
High:
|
|
Low:
|
Max Down |
Low:
|
|
%
|
Post news range |
%
|
|
|
Price change |
|
|
|
Price Change Percentage |
|
|
|
S&P 500 (SPX) |
|
|
%
|
Volume ratio |
%
|
| Volume | ||
| Ticks | ||
|
|
Avg transaction size |
|
Don't Miss Out On The Next BIG Stock Move
Event day
Event Day Chart will not be displayed beyond 90-day period of the event
Performance since event
Time And Velocity Analysis
Be the first to know
Opt in for alerts from News Quantifed
Sign Up Today
Opt-in for
IMDX alerts
Learn More With NQ
Reading the Impact Report
Help Me Understand This Data
Help Me Understand This Data
How NQ Works
What is news-based trading?
And why is it so successful?
And why is it so successful?
Movers & Shakers
The biggest gainers and losers and WHY it moved
IMDX alerts
High impacting Insight Molecular Diagnostics Inc. news events
Weekly update
A roundup of the hottest topics
IMDX
News
- Real-World Evidence and Industry Momentum Builds for iMDx’s Flagship GraftAssure AssayGlobeNewswire
- Insight Molecular Diagnostics Inc. (IMDX) Q4 2025 Earnings Call Transcript [Seeking Alpha]Seeking Alpha
- IMDX Submits GraftAssureDx for FDA Review and Reports Q4 2025 Results [Yahoo! Finance]Yahoo! Finance
- IMDX Submits GraftAssureDx for FDA Review and Reports Q4 2025 ResultsGlobeNewswire
- Insight Molecular Diagnostics Inc. Q4 2025 Earnings Preview [Seeking Alpha]Seeking Alpha
IMDX
Sec Filings
- 3/30/26 - Form 4
- 3/30/26 - Form 4
- 3/30/26 - Form 4
- IMDX's page on the SEC website